BioCentury
ARTICLE | Financial News

Intra-Cellular completes venture financing

September 9, 2013 7:00 AM UTC

million through the conversion of bridge notes. Intra-Cellular said it plans to list on an OTC market but declined to disclose details. Intra-Cellular's ITI-007, a dual serotonin (5-HT2A) receptor a...